News from bausch health companies inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 18, 2022, 07:00 ET Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the...

May 11, 2022, 07:00 ET Bausch Health Announces Participation In Upcoming Investor Conferences

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in several upcoming ...

May 10, 2022, 06:59 ET Bausch Health Companies Inc. Announces First-Quarter 2022 Results

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we") today announced its first-quarter 2022 financial results....

May 06, 2022, 12:08 ET Bausch Health Announces Thomas J. Appio As Chief Executive Officer

Bausch Health Companies Inc. (NYSE/TSX: BHC) (Bausch Health) today announced its full leadership team and Board of Directors, including Chief...

May 03, 2022, 06:59 ET Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Novaliq GmbH, a...

Apr 29, 2022, 07:00 ET Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its first-quarter financial results on Tuesday, May 10, 2022. Bausch...

Apr 28, 2022, 09:43 ET Bausch + Lomb Corporation Announces Launch of IPO and Roadshow

Bausch + Lomb Corporation ("Bausch + Lomb"), a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today...

Apr 28, 2022, 09:40 ET Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that, in connection with its previously announced...

Apr 28, 2022, 06:50 ET Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the...

Apr 27, 2022, 16:32 ET Ortho Dermatologics Will Present Data at the 2022 Florida Society of Dermatology Physician Assistants New Wave Dermatology Conference

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced the presentation of ...

Apr 25, 2022, 06:59 ET Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Novaliq GmbH, a...

Apr 21, 2022, 06:59 ET Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced its exclusive...

Apr 20, 2022, 07:00 ET Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that, in connection with its previously announced...

Apr 18, 2022, 06:59 ET Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the...

Mar 29, 2022, 07:00 ET Bausch Health Will Reduce Debt By $200 Million

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $200 million through the pay...

Mar 24, 2022, 07:00 ET New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy

Bausch Health Companies Inc. (NYSE/TSX: BHC) "Bausch Health" and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest...

Mar 22, 2022, 16:05 ET Gary Gemignani Will Join Solta Medical Corporation As Chief Financial Officer

Solta Medical Corporation ("Solta"), a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), announced that Gary ...

Mar 22, 2022, 06:59 ET Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest prescription...

Mar 03, 2022, 07:00 ET Bausch Health Announces Participation in Upcoming Investor Conferences

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate at two upcoming...

Mar 02, 2022, 06:59 ET Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest prescription...

Mar 01, 2022, 07:00 ET Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings

The Colon Cancer Coalition, a national nonprofit organization focusing on grass roots efforts to increase screening and awareness for colorectal...

Feb 24, 2022, 07:00 ET Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that Sam Eldessouky, executive vice president and...

Feb 23, 2022, 06:59 ET Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance

Fourth-Quarter 2021 Financial Results Revenues of $2.196 Billion GAAP Net Income of $69 Million Adjusted EBITDA (non-GAAP)1 of $909 Million GAAP Cash ...

Feb 22, 2022, 06:59 ET OraPharma Launches OraFit™ Custom Clear Dental Aligner System

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its oral health care business, OraPharma, today announced the U.S. launch of the...

Feb 15, 2022, 07:00 ET Salix Announces 2022 Gastrointestinal Health Scholars Program

Bausch Health Companies Inc. (NYSE/TSX: BHC) "Bausch Health" and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest...